These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9531058

  • 1. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis.
    Marsh Lyle E, Lewis SD, Lehman ED, Gardell SJ, Motzel SL, Lynch JJ.
    Thromb Haemost; 1998 Mar; 79(3):656-62. PubMed ID: 9531058
    [Abstract] [Full Text] [Related]

  • 2. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 3. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
    Biemond BJ, Friederich PW, Levi M, Vlasuk GP, Büller HR, ten Cate JW.
    Circulation; 1996 Jan 01; 93(1):153-60. PubMed ID: 8616922
    [Abstract] [Full Text] [Related]

  • 4. A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous injection.
    Zhao B, Zhang Y, Huang Y, Yu J, Li Y, Wang Q, Ma Y, Song HY, Yu M, Mo W.
    Thromb Haemost; 2017 Jan 05; 117(1):44-56. PubMed ID: 27904902
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S, Johansson K, Kjaer M, Elg M.
    Thromb Haemost; 2010 Dec 05; 104(6):1242-9. PubMed ID: 20806126
    [Abstract] [Full Text] [Related]

  • 6. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW.
    Thromb Haemost; 1994 Sep 05; 72(3):377-80. PubMed ID: 7855787
    [Abstract] [Full Text] [Related]

  • 7. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I, Finkle CD, Winocour PD.
    Thromb Haemost; 1998 Jul 05; 80(1):186-91. PubMed ID: 9684808
    [Abstract] [Full Text] [Related]

  • 8. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R, Lippi A, Subissi A, Agnelli G, Criscuoli M.
    Thromb Haemost; 1996 Sep 05; 76(3):384-92. PubMed ID: 8883275
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B, Bergqvist D.
    Plast Reconstr Surg; 1995 Apr 05; 95(5):894-900. PubMed ID: 7708874
    [Abstract] [Full Text] [Related]

  • 10. Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor.
    Friederich PW, Keller TT, Biemond BJ, Peters RJ, Hornberger W, Büller HR, Levi M.
    Thromb Haemost; 2000 Nov 05; 84(5):858-64. PubMed ID: 11127868
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
    Zhang B, Wieslander JB.
    Microsurgery; 1996 Nov 05; 17(2):89-96. PubMed ID: 8914063
    [Abstract] [Full Text] [Related]

  • 12. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M, Gustafsson D, Deinum J.
    Thromb Haemost; 1997 Oct 05; 78(4):1286-92. PubMed ID: 9364999
    [Abstract] [Full Text] [Related]

  • 13. Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis.
    Fioravanti C, Burkholder D, Francis B, Siegl PK, Gibson RE.
    Thromb Res; 1993 Aug 15; 71(4):317-24. PubMed ID: 8236160
    [Abstract] [Full Text] [Related]

  • 14. [Direct thrombin antagonists].
    Lankes W, Fleischer K, Gulba DC.
    Herz; 2001 Apr 15; 26 Suppl 1():46-52. PubMed ID: 11349627
    [Abstract] [Full Text] [Related]

  • 15. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 15; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN, Girard D, Girardot C, Lochot S, Lunven C, Visconte C.
    Semin Thromb Hemost; 1996 Oct 15; 22(3):233-41. PubMed ID: 8836007
    [Abstract] [Full Text] [Related]

  • 17. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT, Paul W, Emerson M, Cicala C, Page CP.
    Eur J Pharmacol; 1994 Oct 24; 264(2):183-90. PubMed ID: 7851481
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y, Inoue Y, Goto Y, Fukazawa T, Hayashi H.
    Thromb Haemost; 1999 Feb 24; 81(2):250-5. PubMed ID: 10064001
    [Abstract] [Full Text] [Related]

  • 19. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting.
    Muller DW, Gordon D, Topol EJ, Levy RJ, Golomb G.
    Am Heart J; 1996 Feb 24; 131(2):211-8. PubMed ID: 8579010
    [Abstract] [Full Text] [Related]

  • 20. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH.
    Annu Rev Med; 1994 Feb 24; 45():165-77. PubMed ID: 8198374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.